{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:05:51Z","timestamp":1788001551597,"version":"build-2784847793"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cld.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:21:59Z","timestamp":1708474919000},"page":"209-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pathophysiology of Hepatic Encephalopathy"],"prefix":"10.1016","volume":"28","author":[{"given":"Alexander","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Tait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Minacapelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Rustgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cld.2024.01.002_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cld.2020.01.001","article-title":"Epidemiology of hepatic encephalopathy","volume":"24","author":"Elsaid","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2024.01.002_bib2","first-page":"89","article-title":"Hepatic encephalopathy: a review","volume":"9","author":"Kabara S","year":"2021","journal-title":"European Medical Journal"},{"issue":"2","key":"10.1016\/j.cld.2024.01.002_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cld.2020.01.010","article-title":"Clinical Manifestations of Hepatic Encephalopathy","volume":"24","author":"Dellatore","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2024.01.002_bib4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2024.01.002_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cld.2020.01.002","article-title":"Pathophysiology of hepatic encephalopathy","volume":"24","author":"Jaffe","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2024.01.002_bib6","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jceh.2014.06.004","article-title":"Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation","volume":"5","author":"Aldridge","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2024.01.002_bib7","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2215\/CJN.10311013","article-title":"Urea and ammonia metabolism and the control of renal nitrogen excretion","volume":"10","author":"Weiner","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.cld.2024.01.002_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cphy.c120010","article-title":"Renal ammonia metabolism and transport","volume":"3","author":"Weiner","year":"2013","journal-title":"Compr Physiol"},{"issue":"3","key":"10.1016\/j.cld.2024.01.002_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1172\/JCI115673","article-title":"Effect of angiotensin II on ammonia production and secretion by mouse proximal tubules perfused in\u00a0vitro","volume":"89","author":"Nagami","year":"1992","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.cld.2024.01.002_bib10","first-page":"249","article-title":"Biochemical pathways and modulators of renal ammoniagenesis","volume":"16","author":"Tannen","year":"1990","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.cld.2024.01.002_bib11","unstructured":"Cordoba J. and A.T. Blei, Hepatic Encephalopathy, In: M.F.S. Eugene R. Schiff, Willis C. Maddrey, Editor. Schiff\u2019s Diseases of the Liver, 2003. Lippincott Williams & Wilkins; Philadelphia, PA, 593-623."},{"issue":"13","key":"10.1016\/j.cld.2024.01.002_bib12","doi-asserted-by":"crossref","first-page":"9516","DOI":"10.1074\/jbc.M109.092429","article-title":"Glutamine synthetase in muscle is required for glutamine production during fasting and extrahepatic ammonia detoxification","volume":"285","author":"He","year":"2010","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.cld.2024.01.002_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cld.2020.01.003","article-title":"Nonpharmacologic management of hepatic encephalopathy: an Update","volume":"24","author":"Weir","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2024.01.002_bib14","first-page":"CD001939","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","volume":"5","author":"Gluud","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.cld.2024.01.002_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nut.2009.06.027","article-title":"Three targets of branched-chain amino acid supplementation in the treatment of liver disease","volume":"26","author":"Holecek","year":"2010","journal-title":"Nutrition"},{"issue":"2","key":"10.1016\/j.cld.2024.01.002_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cld.2020.01.005","article-title":"Pharmacologic Management of Hepatic Encephalopathy","volume":"24","author":"Mahpour","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2024.01.002_bib17","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.32255","article-title":"L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial","volume":"75","author":"Jain","year":"2022","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2024.01.002_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00004836-199008000-00016","article-title":"Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients","volume":"12","author":"Riggio","year":"1990","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2024.01.002_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003044.pub2","article-title":"Nonabsorbable disaccharides for hepatic encephalopathy","author":"Als-Nielsen","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.cld.2024.01.002_bib20","first-page":"444","article-title":"Acute liver failure: a management challenge for the practicing gastroenterologist","volume":"6","author":"McDowell Torres","year":"2010","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.01.002_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jhep.2004.03.023","article-title":"Normal protein diet for episodic hepatic encephalopathy: results of a randomized study","volume":"41","author":"C\u00f3rdoba","year":"2004","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.01.002_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jceh.2018.04.007","article-title":"Hepatic encephalopathy and sarcopenia: two Faces of the Same metabolic alteration","volume":"9","author":"Lattanzi","year":"2019","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.01.002_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-022-00366-6","article-title":"Hepatic encephalopathy","volume":"8","author":"H\u00e4ussinger","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.cld.2024.01.002_bib24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.510290309","article-title":"Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration","volume":"29","author":"Clemmesen","year":"1999","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2024.01.002_bib25","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0168-8278(00)80110-5","article-title":"Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?","volume":"32","author":"H\u00e4ussinger","year":"2000","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2024.01.002_bib26","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.3390\/jcm9113784","article-title":"Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges","volume":"9","author":"Schindler","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.cld.2024.01.002_bib27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.14309\/ajg.0000000000000384","article-title":"Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice","volume":"115","author":"Bajaj","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2024.01.002_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.14309\/ajg.0000000000000343","article-title":"Ammonia levels do not Guide clinical management of patients with hepatic encephalopathy caused by cirrhosis","volume":"115","author":"Haj","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2024.01.002_bib29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01477-8","article-title":"Correlation between ammonia levels\u00a0and the severity of hepatic encephalopathy","volume":"114","author":"Ong","year":"2003","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.cld.2024.01.002_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/gut.2004.061754","article-title":"Predictive value of arterial ammonia for complications and outcome in acute liver failure","volume":"55","author":"Bhatia","year":"2006","journal-title":"Gut"},{"issue":"4284","key":"10.1016\/j.cld.2024.01.002_bib31","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1126\/science.14400","article-title":"Glutamine synthetase: glial localization in brain","volume":"195","author":"Martinez-Hernandez","year":"1977","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.cld.2024.01.002_bib32","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/nm.3400","article-title":"Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering","volume":"19","author":"Rangroo Thrane","year":"2013","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.cld.2024.01.002_bib33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s11064-016-2014-x","article-title":"Neurotoxicity of ammonia","volume":"42","author":"Oja","year":"2017","journal-title":"Neurochem Res"},{"issue":"6","key":"10.1016\/j.cld.2024.01.002_bib34","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/hep.21235","article-title":"Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis","volume":"43","author":"Haussinger","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2024.01.002_bib35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.510250406","article-title":"Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats","volume":"25","author":"Vogels","year":"1997","journal-title":"Hepatology"},{"issue":"3\u20134","key":"10.1016\/j.cld.2024.01.002_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/B:MEBR.0000043979.58915.41","article-title":"Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint","volume":"19","author":"Ahboucha","year":"2004","journal-title":"Metab Brain Dis"},{"issue":"7","key":"10.1016\/j.cld.2024.01.002_bib37","first-page":"CD002798","article-title":"Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy","volume":"7","author":"Goh","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.cld.2024.01.002_bib38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neuint.2010.03.012","article-title":"Altered glial-neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy","volume":"57","author":"Butterworth","year":"2010","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.cld.2024.01.002_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1043-2760(01)00503-3","article-title":"Neurosteroids: biochemistry and clinical significance","volume":"13","author":"Mellon","year":"2002","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.cld.2024.01.002_bib40","doi-asserted-by":"crossref","first-page":"G400","DOI":"10.1152\/ajpgi.00073.2015","article-title":"GR3027 antagonizes GABAA receptor-potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy","volume":"309","author":"Johansson","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"10.1016\/j.cld.2024.01.002_bib41","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00213-018-4864-1","article-title":"GR3027 reversal of neurosteroid-induced, GABA-A receptor-mediated inhibition of human brain function: an allopregnanolone challenge study","volume":"235","author":"Johansson","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"2\u20133","key":"10.1016\/j.cld.2024.01.002_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0197-0186(02)00027-X","article-title":"Glutamate transporters in hyperammonemia","volume":"41","author":"Butterworth","year":"2002","journal-title":"Neurochem Int"},{"issue":"2","key":"10.1016\/j.cld.2024.01.002_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.abb.2013.02.010","article-title":"Neurotransmitter receptor alterations in hepatic encephalopathy: a review","volume":"536","author":"Palomero-Gallagher","year":"2013","journal-title":"Arch Biochem Biophys"},{"issue":"1\u20132","key":"10.1016\/j.cld.2024.01.002_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00684999","article-title":"Brain monoamines in human hepatic encephalopathy","volume":"43","author":"Jellinger","year":"1978","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.cld.2024.01.002_bib45","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","article-title":"Inflammation-associated depression: from serotonin to kynurenine","volume":"36","author":"Dantzer","year":"2011","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.cld.2024.01.002_bib46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-510X(99)00169-0","article-title":"Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome","volume":"170","author":"Albrecht","year":"1999","journal-title":"J\u00a0Neurol Sci"},{"issue":"2","key":"10.1016\/j.cld.2024.01.002_bib47","first-page":"CD003047","article-title":"Dopamine agents for hepatic encephalopathy","volume":"2014","author":"Junker","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.cld.2024.01.002_bib48","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0016-5085(92)91122-K","article-title":"Serum levels of cytokines in chronic liver diseases","volume":"103","author":"Tilg","year":"1992","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2024.01.002_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2024.01.002_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/diseases7040058","article-title":"Role of gut dysbiosis in liver diseases: what have We Learned So far?","volume":"7","author":"Fukui","year":"2019","journal-title":"Diseases"},{"issue":"5","key":"10.1016\/j.cld.2024.01.002_bib51","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2024.01.002_bib52","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jhep.2019.01.008","article-title":"Chronic hyperammonemia induces peripheral inflammation that leads to cognitive impairment in rats: Reversed by anti-TNF-\u03b1 treatment","volume":"73","author":"Balzano","year":"2020","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.01.002_bib53","doi-asserted-by":"crossref","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","article-title":"Linkage of gut microbiome with cognition in hepatic encephalopathy","volume":"302","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"10.1016\/j.cld.2024.01.002_bib54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4161\/gmic.28684","article-title":"The role of microbiota in hepatic encephalopathy","volume":"5","author":"Bajaj","year":"2014","journal-title":"Gut Microb"},{"issue":"6","key":"10.1016\/j.cld.2024.01.002_bib55","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.01.002_bib56","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2024.01.002_bib57","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.cld.2024.01.002_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2013.12.021","article-title":"Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy","volume":"12","author":"Mullen","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"17","key":"10.1016\/j.cld.2024.01.002_bib59","doi-asserted-by":"crossref","first-page":"e6723","DOI":"10.1097\/MD.0000000000006723","article-title":"Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis","volume":"96","author":"Bian","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.cld.2024.01.002_bib60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2362.2007.01778.x","article-title":"Pathogenesis of hepatic encephalopathy: the tumour necrosis factor-alpha theory","volume":"37","author":"Odeh","year":"2007","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.cld.2024.01.002_bib61","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1478-3231.2004.0894.x","article-title":"Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure","volume":"24","author":"Odeh","year":"2004","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.cld.2024.01.002_bib62","first-page":"474","article-title":"Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells","volume":"44","author":"Duchini","year":"1996","journal-title":"J Investig Med"},{"issue":"3","key":"10.1016\/j.cld.2024.01.002_bib63","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0016-5085(99)70457-9","article-title":"Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction","volume":"117","author":"Rose","year":"1999","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2024.01.002_bib64","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF02109357","article-title":"Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy","volume":"10","author":"Butterworth","year":"1995","journal-title":"Metab Brain Dis"},{"issue":"5","key":"10.1016\/j.cld.2024.01.002_bib65","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.510230523","article-title":"Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis","volume":"23","author":"Marchesini","year":"1996","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2024.01.002_bib66","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1365-2036.2010.04448.x","article-title":"Clinical trial: oral zinc in hepatic encephalopathy","volume":"32","author":"Takuma","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.cld.2024.01.002_bib67","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s10620-017-4597-8","article-title":"Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach","volume":"62","author":"Jim\u00e9nez","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.cld.2024.01.002_bib68","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/ajg.2009.293","article-title":"Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis","volume":"104","author":"Guevara","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2024.01.002_bib69","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/j.1572-0241.2008.02102.x","article-title":"Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts","volume":"103","author":"Riggio","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2024.01.002_bib70","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11011-010-9172-3","article-title":"Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence","volume":"25","author":"Cordoba","year":"2010","journal-title":"Metab Brain Dis"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T05:41:28Z","timestamp":1711518088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326124000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1089326124000023"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2024.01.002","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology of Hepatic Encephalopathy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}